Hjem › Kronisk fase myeloid leukæmi › New York
Kronisk fase myeloid leukæmi kliniske forsøg i New York
5 studier for Kronisk fase myeloid leukæmi søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1068, Rochester
- Ascentage Investigative Site #1053, Shirley
- Ascentage Investigative Site #1160, Stony Brook
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06423911Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
- Roswell Park Comprehensive Cancer Center, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT04838041A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- NY Cancer and Blood Specialists, East Setauket
- SUNY Upstate Medical University, Syracuse
RekruttererObservationsstudie
Alder 18 til 100 · Alle køn · Opdateret 20. jul. 2026 · NCT07091019A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. apr. 2026 · NCT05304377A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 12. jan. 2026 · NCT06163430Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.